NEW YORK (GenomeWeb) – CombiMatrix today reported a 37 percent increase in second quarter revenues, driven by higher test volumes in its reproductive health and pediatric segments as well as improved test reimbursement across all segments.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.